Poly Medicure (POLYMED) | Stock Overview & Key Data
Poly Medicure Performance Comparison
Stock Range
Today's Range
52 Week Range
All-Time High: ₹3,357.80 on October 28, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Join Our India Telegram Channel
Get Instant Market Updates: 52-Week High/Low Alerts, Breakout Notifications & Expert Stock Analysis Delivered To Your Phone. Join Traders Making Informed Decisions Daily!
Financial Highlights
Quarter Income Flow
Sep 30, 2025
Annual Income Flow
2025
Dividend Information
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Poly Medicure
POLYMED
|
151.00B Mid-cap | 9.26% | 0.80% | 20.33% | -19.36% | -13.29% | -31.00% | 33.68% | 70.32% | 703.44% | 4,602.06% | 4,602.06% |
|
Dr Agarwal's Health
AGARWALEYE
|
138.86B Mid-cap | -2.72% | -2.40% | 3.65% | -11.79% | -12.18% | 17.19% | 9.38% | 9.38% | 9.38% | 9.38% | 9.38% |
|
Tarsons Products
TARSONS
|
11.01B Small-cap | -0.12% | -0.11% | 8.87% | -10.58% | -11.95% | -47.38% | -64.08% | -74.91% | -74.91% | -74.91% | -74.91% |
|
Laxmi Dental
LAXMIDENTL
|
10.40B Small-cap | 1.49% | 12.83% | 31.31% | -15.20% | -17.46% | -47.17% | -55.90% | -55.90% | -55.90% | -55.90% | -55.90% |
|
Prevest Denpro
PREVEST
|
5.42B Small-cap | -0.84% | -5.49% | -5.28% | -20.44% | -18.59% | -20.44% | -9.34% | 356.55% | 356.55% | 356.55% | 356.55% |
|
Shree Pacetronix
SHREEPAC
|
532.08M Small-cap | -0.39% | 4.04% | 31.20% | -46.19% | -22.04% | 73.55% | -37.38% | 1,403.82% | 743.43% | 289.00% | 1,913.14% |
Ownership & Short Interest
Calculate Your Poly Medicure Investment Returns
Long-Term Investment Performance Analysis
Poly Medicure stock price in Jul 2016 was ₹201.52, A ₹1,000.00 lump sum investment in Poly Medicure made 9 years ago would be worth approximately ₹7,497.52 today, representing a exceptional return of 649.75%. This translates to an annualized return (CAGR) of 22.55%.
9 Years 10 Months Investment Scenario (Jul 2016 - Jun 2026)
Investment Breakdown
Value Comparison
Disclaimer: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing. Past performance does not guarantee future results.
Frequently Asked Questions
- What is POLYMED's 52-week high and low?
- In the last 52 weeks, Poly Medicure reached a high of ₹2,316.60 (on July 2, 2025) and a low of ₹1,182.00 (on March 30, 2026).
- What is the market cap and P/E ratio for POLYMED?
- Curious about Poly Medicure's size and valuation? Its market capitalization stands at 151.00B. When it comes to valuation, the P/E ratio (trailing twelve months) is 43.53, and the forward P/E (looking ahead) is 37.61.
- Does POLYMED pay dividends? If so, what's the yield?
- Yes, Poly Medicure is a dividend-paying stock. Investors have recently enjoyed a trailing annual dividend yield of 0.33%, and the company has paid an average of ₹3.17 per share annually over the past 3 years.
- Who are Poly Medicure's main competitors or similar companies to consider before investing?
When looking at Poly Medicure, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Dr Agarwal's Health
AGARWALEYE138.86B Healthcare Medical Instruments & Supplies 17.19% 9.38% Tarsons Products
TARSONS11.01B Healthcare Medical Instruments & Supplies -47.38% -64.08% Laxmi Dental
LAXMIDENTL10.40B Healthcare Medical Instruments & Supplies -47.17% -55.90% Prevest Denpro
PREVEST5.42B Healthcare Medical Instruments & Supplies -20.44% -9.34% Shree Pacetronix
SHREEPAC532.08M Healthcare Medical Instruments & Supplies 73.55% -37.38% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Poly Medicure Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Poly Medicure's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 12.24%, the Debt to Equity ratio from the most recent quarter is 8.17, and its Gross Profit Margin stands at 36.69%.
- What is the recent revenue and earnings growth for POLYMED?
- Looking at Poly Medicure's growth, its revenue over the trailing twelve months (TTM) was INR18B. Compared to the same quarter last year (YoY), quarterly revenue grew by 16.40%, and quarterly earnings saw a YoY growth of -16.80%.
- How much of POLYMED stock is held by insiders and institutions?
- Wondering who owns Poly Medicure stock? Company insiders (like executives and directors) hold about 66.86% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 18.77%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.